selenium has been researched along with Familial Nonmedullary Thyroid Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Amini, S; Askari, G; Bagherniya, M; Golshani, M; Hajiahmadi, S; Iraj, B; Moslehi, M | 1 |
| Dong, J; Feng, J; Fu, H; Ge, S; Liao, L; Shan, Y; Sun, M; Tian, Y; Yao, J; Zhao, J | 1 |
| Borković-Mitić, S; Gavrović-Jankulović, M; Jagodić, J; Krstić, Đ; Manojlović, D; Mitić, B; Paunović, I; Rovčanin, B; Stojsavljević, A; Živaljević, V | 1 |
1 trial(s) available for selenium and Familial Nonmedullary Thyroid Cancer
| Article | Year |
|---|---|
The effect of selenium supplementation on sonographic findings of salivary glands in papillary thyroid cancer (PTC) patients treated with radioactive iodine: study protocol for a double-blind, randomized, placebo-controlled clinical trial.
Topics: Dietary Supplements; Humans; Inflammation; Iodine Radioisotopes; Iran; Randomized Controlled Trials as Topic; Salivary Glands; Selenium; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy | 2023 |
2 other study(ies) available for selenium and Familial Nonmedullary Thyroid Cancer
| Article | Year |
|---|---|
The association between serum selenium levels and pathological features of papillary thyroid cancer in 284 patients.
Topics: Carcinoma, Papillary; Cross-Sectional Studies; Female; Humans; Male; Retrospective Studies; Selenium; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2023 |
Cadmium as main endocrine disruptor in papillary thyroid carcinoma and the significance of Cd/Se ratio for thyroid tissue pathophysiology.
Topics: Cadmium; Endocrine Disruptors; Female; Humans; Male; Mass Spectrometry; Middle Aged; Selenium; Thyroid Cancer, Papillary | 2019 |